[HTML][HTML] Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z Su, J Zhao, S Ke, J Zhang, X Liu… - Experimental and …, 2018 - spandidos-publications.com
A newly‑developed platform, integrating subtraction enrichment and immunostaining‑
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …

[PDF][PDF] Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z SU, J ZHAO, S KE, J ZHANG, X LIU… - EXPERIMENTAL …, 2018 - 122.114.197.222
A newly-developed platform, integrating subtraction enrichment and immunostaining-
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …

Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z Su, J Zhao, S Ke, J Zhang, X Liu… - Experimental and …, 2018 - search.proquest.com
A newly-developed platform, integrating subtraction enrichment and immunostaining-
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …

[PDF][PDF] Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z SU, J ZHAO, S KE, J ZHANG, X LIU… - EXPERIMENTAL …, 2018 - pdfs.semanticscholar.org
A newly-developed platform, integrating subtraction enrichment and immunostaining-
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …

[HTML][HTML] Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z Su, J Zhao, S Ke, J Zhang, X Liu… - Experimental and …, 2018 - spandidos-publications.com
A newly‑developed platform, integrating subtraction enrichment and immunostaining‑
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …

Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z Su, J Zhao, S Ke, J Zhang, X Liu… - Experimental and …, 2018 - pubmed.ncbi.nlm.nih.gov
A newly-developed platform, integrating subtraction enrichment and immunostaining-
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …

[HTML][HTML] Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z Su, J Zhao, S Ke, J Zhang, X Liu, Y Wang… - Experimental and …, 2018 - ncbi.nlm.nih.gov
A newly-developed platform, integrating subtraction enrichment and immunostaining-
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …

Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z SU, J ZHAO, S KE, J ZHANG, X LIU… - EXPERIMENTAL …, 2018 - ingentaconnect.com
A newlydeveloped platform, integrating subtraction enrichment and
immunostainingfluorescence in situ hybridization (SE-iFISH), was applied to analyze the …

Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report.

Z Su, J Zhao, S Ke, J Zhang, X Liu, Y Wang… - Experimental and …, 2018 - europepmc.org
A newly-developed platform, integrating subtraction enrichment and immunostaining-
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …

[PDF][PDF] Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report

Z SU, J ZHAO, S KE, J ZHANG, X LIU… - EXPERIMENTAL …, 2018 - 122.114.197.222
A newly-developed platform, integrating subtraction enrichment and immunostaining-
fluorescence in situ hybridization (SE-iFISH), was applied to analyze the clinical significance …